Диссертация (1145983), страница 32
Текст из файла (страница 32)
- 2006. - Т. 2, № 1. - С. 68-72.49. Торшин, И. Ю. Гены и цереброваскулярная патология (гены и нуклеотидныеполиморфизмы при отдельных видах физиологических сдвигов и патологическихпроцессов) / И. Ю. Торшин, О. А. Громова, А. А. Никонов // Журнал неврологии ипсихиатрии им. С.С. Корсакова. - 2009. - Том 109, № 5. - С. 77-83.50. Трифонова,Е.А.Молекулярно-генетическийанализфакторовнаследственнойтромбофилии при гестозе / Е. А. Трифонова, Т. А. Агаркова, Н. А. Габитова [и др.] //Сибирский медицинский журнал.
- 2010. - Т. 25, № 4 (вып. 2). - С. 34-36.51. Тюрина, Е. П. Изменение липидного метаболизма плаценты у беременных с гестозом / Е.П. Тюрина, Е. В. Котлова, А. П. Власов [и др.] // Известия высших учебных заведений.Поволжский регион. Медицинские науки. - 2011. - № 4. - С. 89-96.52. Халфорд-Князева, И. П. Генетические маркеры прогнозирования преэклампсии / И.
П.Халфорд-Князева, В. Е. Радзинский, Л. М. Самоходская, Е. Б. Яровая // Доктор.руГинекология. - 2013. - № 7 (85). - С. 58-66.53. Ческидова,Н.Б.ИзучениеассоциацииGLN27GLUполиморфизмагенаβ2-адренорецепторов у больных эссенциальной гипертонией / Н. Б.Ческидова, О. А. Пак, А.Г. Полупанов, Т. А. Романова // Вестник КРСУ. - 2005. - Т. 5, № 5. - С. 61-64.54. Шифман, Е. М.
Активированный протеин С и преэклампсия / Е. М. Шифман, Е. Г.Гуменюк, А. А. Ившин / Российский медицинский журнал. - 2006. -№ 3. - С.49-53.55. Шулутко Б. И. Артериальная гипертензия / Б. И. Шулутко. - СПб. : Ренкор, 2001. - 382 с.56. Acton, S. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels andbody mass index in a white population / S.
Acton, D. Osgood, M. Donoghue, D. [et al.] //Arterioscler Thromb Vasc Biol. - 1999. - Vоl. 19, № 7. - P. 1734-1743.57. Adams, E. M. Familial aspects of preeclampsia and hypertension in pregnancy / E. M. Adams,A. Finlayson // Lancet. - 1961. - Vоl. 2, № 7217. - P. 1375-1378.58. Agachan, B. Association of monocyte chemotactic protein-1 and CC chemokine receptor 2 genevariants with preeclampsia / B.
Agachan, R. Attar, E. Isbilen [et al.] // J Interferon CytokineRes. - 2010. - Vоl. 30, № 9. - P. 673-676.59. Aggarwal, P. K. Maternal EDN1 G5665T polymorphism influences circulating endothelin-1levels and plays a role in determination of preeclampsia phenotype / P. K. Aggarwal, V. Jain, R.Srinivasan, V. Jha // J Hypertens. - 2009. - Vоl. 27, № 10. - P. 2044-2050.13360. Aggarwal, S. Preeclampsia in North Indian women: the contribution of genetic polymorphisms/ S. Aggarwal, N. Dimri, I. Tandon, S.Agarwal // J Obstet Gynaecol Res. - 2011.
- Vоl. 37, №10. - P. 1335-1341.61. Ahmad, U. Strong association of a renin intronic dimorphism with essential hypertension / U.Ahmad, D. Saleheen, A. Bokhari, P. M. Frossard // Hypertens. Res. ─ 2005. ─ Vol. 28, № 4. ─P. 339–344.62. Alvim R. de O., BDKRB2 +9/−9 polymorphism is associated with higher risk for diabetesmellitus in the brazilian general population / R.
de O. Alvim, P. C. J. L. Santos, R. M.Nascimento [et al.] // Experimental Diabetes Research. - 2012. - Vоl. 2012, Article ID 480251. 4 p.63. Ariza, M. J. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceridelevels and hypertriglyceridemia: results of the ICARIA genetic sub-study / M. J. Ariza, M. A.Sánchez-Chaparro, F. J. Barón [et al.] // BMC Med Genet. - 2010. - Vol. 11: 66. - 10 p.64.
Ark, M. Rho-associated protein kinase II (rock II) expression in normal and preeclamptichuman placentas / M. Ark, N. Yilmaz, G. Yazici [et al.] // Placenta. - 2005. - Vol. 26, № 1. - P.81-84.65. Arngrimsson, R. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsiaon chromosome 2p13 / R. Arngrimsson, S. Sigurardottir, M.L. Frigge [et al.] // Hum Mol Genet.- 1999. -Vol.
8. - P. 1799-1805.66. Arngrimsson, R. Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome/ R. Arngrimsson, H. Bjornsson, R. T. Geirsson // Hypertension in pregnancy. - 1995. - Vol. 14,№ 1. - P. 27-38.67. Arngrimsson, R. Angiotensinogen: a candidate gene involved in preeclampsia? / R.Arngrimsson, S. Purandare, M. Connor [et al.] // Nat. Genet. - 1993.
- Vol. 4. - P. 114-115.68. Augoff, K. miR-31 is a broad regulator of β1-integrin expression and function in cancer cells /K. Augoff, M. Das, K. Bialkowska [et al.] // Mol Cancer Res. - 2011. - Vol. 9, № 11. - P. 15001508.69. Austin, M. A. Plasma triglyceride as a risk factor for cardiovascular disease / M. A. Austin //Can J Cardiol. - 1998. - Vol. 14, Suppl B. - P. 14B-17B.70. Ayaz, A.
Neonatal outcome in pre-eclamptic patients / A. Ayaz, T. Muhammad, S. A. Hussain,S. Habib // J Ayub Med Coll Abbottabad. - 2009. -Vol. 21, № 2. - P. 53-55.71. Bai, Y. Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cellinvasion via modulating ActRIIA expression / Y. Bai, W.
Yang, H. X. Yang [et al.] // PLoSOne. - 2012. - Vol. 7, № 6: e38875. - 10 p.13472. Bashford, M. T. Angiotensinogen and endothelial nitric oxide synthase gene polymorphismsamong Hispanic patients with preeclampsia / M. T. Bashford, L. A. Hefler, T. W. Vertrees [etal.] // Am J Obstet Gynecol. - 2001. –Vol. 184, № 7. - P. 1345-1350.73. Bell, M. J. Variation in endoglin pathway genes is associated with preeclampsia: a case-controlcandidate gene association study / M.
J. Bell, J. M. Roberts, S. A. Founds [et al.] // BMCPregnancy Childbirth. - 2013. - Vol. 13: 82. - 9 p.74. Bellamy, L. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematicreview and meta-analysis / L. Bellamy, J. P. Casas, A. D. Hingorani, D. J. Williams // BMJ. 2007. -Vol. 335, № 7627. - P. 974-986.75. Belo, L.
Apolipoprotein E and cholesterylester transfer protein polymorphisms in normal andpreeclamptic pregnancies / L. Belo, D. Gaffney, M. Caslake [et al.] // Eur J Obstet GynecolReprod Biol. - 2004. -Vol. 112, № 1. - P. 9-15.76. Bengtsson, K. Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type2 diabetes / K. Bengtsson, M. Orho-Melander, O. Melander [et al.] // Hypertension.
- 2001. Vol. 37, № 5. - P. 1303-1308.77. Benjamini, Y. Controlling the false discovery rate: a practical and powerful approach tomultiple testing / Y. Benjamini, Y. Hochberg // Journal of the Royal Statistical. - 1995. Vol. 57,№ 1. - P. 289-300.78. Bernard, N. The combination of ApoCIII, hepatic lipase and hormono sensitive lipase genepolymorphisms suggests an association with susceptibility to gestational hypertension / N.Bernard, J. Girouard, J. C. Forest, Y. Giguere // J Hum Genet. - 2007. - Vol. 52, № 3. - P.
244254.79. Betoni, J. S. MicroRNA analysis in placentas from patients with preeclampsia: comparison ofnew and published results / J. S. Betoni, K. Derr, M. C. Pahl [et al.] // Hypertens Pregnancy. 2013. - Vol. 32, № 4. - P. 321-339.80. Bianco, A. T. Pregnancy outcome and weight gain recommendations for the morbidly obesewoman / A. T.
Bianco, S. W. Smilen, Y. Davis [et al.] // Obstet Gynecol. - 1998. - Vol. 91, № 1.- P. 97-102.81. Boes, E. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: asystematic in-depth review / E. Boes, S. Coassin, B. Kollerits [et al.] // Exp Gerontol. - 2009. Vol. 44, № 3. - P. 136-160.82. Bouba,I. Interaction between the polymorphisms of the renin-angiotensin system inpreeclampsia / I.
Bouba, G. Makrydimas, R. Kalaitzidis [et al.] // Eur J Obstet Gynecol ReprodBiol. - 2003. - Vol. 110, № 1. - P. 8-11.13583. Bray, M. S. Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as asusceptibility locus for human hypertension / M. S. Bray, J. Krushkal, L. Li [et al.] //Circulation. - 2000. - Vol. 101, № 25. - P. 2877-2882.84. Buchholz, T. Polymorphisms in the ACE and PAI-1 genes are associated with recurrentspontaneous miscarriages / T. Buchholz, P. Lohse, N. Rogenhofer [et al.] // Hum Reprod. 2003. - Vol. 18, № 11.
- P. 2473-2477.85. Buurma, A. J. Genetic variants in pre-eclampsia: a meta-analysis / A. J. Buurma, R. J. Turner,J. H. Driessen, A. L. Mooyaart [et al.] // Hum Reprod Update. - 2013. - Vol. 19, № 3. - P. 289303.86. Camilleri, R. S. -455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombinG20210A mutation and MTHFR C677T, and placental vascular complications / R. S.
Camilleri,D. Peebles, C. Portmann [et al.] // Blood Coagul Fibrinolysis. - 2004. - Vol. 15, № 2. - P. 139147.87. Caughey, A. Maternal ethnicity, paternal ethnicity and parental ethnic discordance: predictors ofpre-eclampsia / A. Caughey, N. Stotland, A. Washington, G. Escobar // Obstet Gynecol. - 2005.- Vol. 106, № 1. - P. 156-161.88. Chan, D. C. Apolipoproteins as markers and managers of coronary risk / D. C. Chan, G.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
